Biomarkers in Prenatal Drug Exposure Studies, Design Issues

Michael B. Bracken from Yale University authored a paper discussing methodological considerations for using biologic markers in epidemiological research on prenatal drug exposure. The paper likely contains a discussion of study design challenges, data collection issues, and analytical approaches. Its publication on paperswithcode suggests it may be associated with computational or methodological research.

Use Cases

• Analyzing methodological frameworks for biomarker integration in epidemiological studies (inferred from domain, verify after download)
• Reviewing design challenges for studies of prenatal drug exposure (inferred from domain, verify after download)
• Benchmarking analytical approaches for handling biomarker data in observational research (inferred from domain, verify after download)

Strengths

• Authored by a researcher from Yale University.
• Published on the paperswithcode platform, which often links to code and methodological resources.

Limitations

• Metadata is minimal; actual content requires verification after download.
• The license is listed as 'closed', which may restrict use.
• Row count, file formats, and sample data are unknown.

Provenance

Source

paperswithcode